Las disciplinas ómicas y la tuberculosis en el Perú: impacto, diagnóstico y tratamiento

Heinner  Guio

doi:10.37711/rpcs.2022.4.3.381

Authors

Heinner Guio Universidad de Huánuco, Huánuco, Perú https://orcid.org/0000-0003-0078-1188

DOI:

https://doi.org/10.37711/rpcs.2022.4.3.381

Keywords:

OMICAS, tuberculosis, Peru, impact, diagnosis, treatment

Abstract

After the publication of the human genome data, different lines of research have been generated in the fields of biology, biotechnology, drug development and even historical implications to understand the mechanisms of evolution and migration of human beings on the planet.

Downloads

Download data is not yet available.

References

Craig J, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science [Internet]. 2001 Feb 16 [consultado 2022 Sep 25]; 291(5507): 1304–51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11181995/

Bonadonna LV, Saunders MJ, Zegarra R, Evans C, Ale-gria-Flores K, Guio H. Why wait? The social determinants underlying tuberculosis diagnostic delay. Caylà JA, editor. PLoS One [Internet]. 2017 Sep 25 [consultado 2018 Mar 24]; 12(9): e0185018. Disponible en: http://dx.plos.org/10.1371/journal.pone.0185018

Galarza M, Tarazona D, Borda V, Agapito JC, Guio H. Evidence of Clonal Expansion in the Genome of a Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolate from Peru. Genome Announc [Internet]. 2014 Feb 27 [consultado 2022 Sep 25]; 2(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/24578270/

Guio H, Tarazona D, Galarza M, Borda V, Curitomay R. Genome analysis of 17 extensively drug-resistant strains reveals new potential mutations for resistance. Genome Announc [Internet]. 2014 [consultado 2022 Sep 25]; 2(4). Disponible en: https://pubmed.ncbi.nlm.nih.gov/25081269/

Tarazona D, Galarza M, Levano KS, Guio H. [Comparative genomic analysis of peruvian strains of Mycobacterium tuberculosis]. Rev Peru Med Exp Salud Publica [Internet]. 2016 Apr 1 [consultado 2022 Sep 25]; 33(2): 256–63. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27656924/

Levano KS, Jaramillo-Valverde L, Tarazona DD, Sanchez C, Capristano S, Vásquez-Loarte T, et al. Allelic and geno-typic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients. Mol Genet genomic Med [Internet]. 2021 Oct 1 [consultado 2022 Sep 25]; 9(10). Disponible en: https://pubmed.ncbi.nlm.nih.gov/34510815/

Jaramillo-Valverde L, Levano KS, Tarazona DD, Vasquez-Dominguez A, Toledo-Nauto A, Capristano S, et al. GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients. Int J Mol Sci [Internet]. 2022 Oct 1 [consultado 2022 Sep 25]; 23(19). Disponible en: https://pubmed.ncbi.nlm.nih.gov/36232322/

Luo Y, Suliman S, Asgari S, Amariuta T, Baglaenko Y, Martínez-Bonet M, et al. Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians. Nat Commun [Internet]. 2019 Dic 1 [consultado 2022 Sep 25]; 10(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/31434886/

Ganachari M, Guio H, Zhao N, Flores-Villanueva PO. Host gene-encoded severe lung TB: from genes to the potential pathways. Genes Immun [Internet]. 2012 Dec [consultado 2022 Sep 25]; 13(8): 605–20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22992722/

Fu Y, Yi Z, Wu X, Li J, Xu F. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol [Internet]. 2011 Dic [consultado 2022 Sep 25]; 49(12) :4246–51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21998423/

Yareta J, Galarza M, Capristano S, Pellón O, Sánchez C, Ballon J, et al. Differential expression of circulating micro-RNAs in patients with active and latent tuberculosis. Rev Peru Med Exp Salud Publica [Internet]. 2020 [consultado 2022 Sep 25]; 37(1): 51–6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32520192/